GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (OTCPK:PMCUF) » Definitions » Intrinsic Value: Projected FCF

Pro Medicus (Pro Medicus) Intrinsic Value: Projected FCF : $3.29 (As of May. 16, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pro Medicus Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-16), Pro Medicus's Intrinsic Value: Projected FCF is $3.29. The stock price of Pro Medicus is $79.11. Therefore, Pro Medicus's Price-to-Intrinsic-Value-Projected-FCF of today is 24.1.

The historical rank and industry rank for Pro Medicus's Intrinsic Value: Projected FCF or its related term are showing as below:

PMCUF' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 2.59   Med: 12.15   Max: 24.05
Current: 24.05

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Pro Medicus was 24.05. The lowest was 2.59. And the median was 12.15.

PMCUF's Price-to-Projected-FCF is ranked worse than
98.39% of 311 companies
in the Healthcare Providers & Services industry
Industry Median: 1.3 vs PMCUF: 24.05

Pro Medicus Intrinsic Value: Projected FCF Historical Data

The historical data trend for Pro Medicus's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Intrinsic Value: Projected FCF Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 1.21 1.85 2.58 3.31

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.58 - 3.31 -

Competitive Comparison of Pro Medicus's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, Pro Medicus's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Pro Medicus's Price-to-Projected-FCF falls into.



Pro Medicus Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Pro Medicus's Free Cash Flow(6 year avg) = $19.81.

Pro Medicus's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jun23)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*19.814571428571+93.138*0.8)/104.566
=3.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus  (OTCPK:PMCUF) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Pro Medicus's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=79.11/3.5289434963422
=22.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (Pro Medicus) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Pro Medicus (Pro Medicus) Headlines

From GuruFocus

Visage Introduces Visage 7 Video Reports at RSNA21

By PRNewswire PRNewswire 11-23-2021

Visage Soars with CloudPACS at RSNA 2023

By PRNewswire 11-14-2023

Visage Joins the AWS Partner Network

By PRNewswire PRNewswire 06-27-2022

Proven Enterprise Imaging with Visage at RSNA 2018

By PRNewswire PRNewswire 11-14-2018

Visage Powers CloudPACS at HIMSS 2021

By PRNewswire PRNewswire 08-05-2021

Visage Signs Mercy for Visage 7 Open Archive

By PRNewswire PRNewswire 07-31-2018

Visage Introduces Semantic Annotations for Visage 7

By PRNewswire PRNewswire 12-01-2019

Visage Signs Ludwig-Maximilians-Universit�t for PACS

By PRNewswire PRNewswire 10-16-2020

Momentum Continues for Visage at RSNA 2020

By PRNewswire PRNewswire 11-30-2020

Visage Speeds Ahead with CloudPACS at RSNA 2021

By PRNewswire PRNewswire 11-16-2021